ISRIB

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameISRIB
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2B stimulants
TargetsEukaryotic translation initiation factor 2B
Therapy Area/IndicationsDown Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsDown Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A